Daniel E. Hilleman

Pharmacoeconomic Evaluation of COPD

Daniel E. Hilleman, Naresh A. Dewan, Mark A. Malesker et al. · CHEST Journal · 2000 · 286 citations

Pulmonary Care, Health Policy, Health Economics +6

Intensive Smoking Cessation Intervention Reduces Mortality in High-Risk Smokers With Cardiovascular Disease

Syed M. Mohiuddin, Aryan N. Mooss, Claire Hunter et al. · CHEST Journal · 2007 · 280 citations

Tobacco Cessation, Tobacco Control, Cardiovascular Disease +6

Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients*

Greet Van den Berghe, Pieter Wouters, Katrien Kesteloot et al. · Critical Care Medicine · 2006 · 201 citations

Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging

Naresh C. Gupta, Dennis J. Esterbrooks, Daniel E. Hilleman et al. · Journal of the American College of Cardiology · 1992 · 177 citations

Positron Emission Tomography, Heart Failure, Engineering +12

Pharmacoeconomic Evaluation of a Combination of Ipratropium Plus Albuterol Compared With Ipratropium Alone and Albuterol Alone in COPD

Mitchell Friedman, Charles W. Serby, Shailendra Menjoge et al. · CHEST Journal · 1999 · 174 citations

Asthma, Health Economics, Pharmacoeconomic Evaluation +6